TREA

97540286 - BASILEA PHARMACEUTICALS

Follow

Information

  • Trademark
  • 97540286
  • Serial Number
    97540286
  • Filing Date
    August 08, 2022
    2 years ago
  • Transaction Date
    August 14, 2024
    5 months ago
  • Status Date
    August 13, 2024
    5 months ago
  • Published for Opposition Date
    June 27, 2023
    a year ago
  • Location Date
    August 22, 2023
    a year ago
  • Status Code
    731
  • Current Location
    INTENT TO USE SECTION
    Employee Name
    MARTIN, JENNIFER MCGAR
  • Attorney Name
    Evan A. Raynes
    Law Office Assigned Location Code
    M70
  • Owners
Information
Mark Drawing Code
4
Mark Identification
BASILEA PHARMACEUTICALS
Case File Statements
  • GS0051: Pharmaceutical and veterinary products and preparations for the treatment and prevention of dermatological conditions, namely, eczema, inflammation, infection, warts, psoriasis, aging of the skin, ultra violet radiation and cancer; Pharmaceutical and veterinary products and preparations for the treatment and prevention of infections caused by bacteria, fungi, viruses, and rheumatoid arthritis; Pharmaceutical and veterinary products and preparations for the treatment and prevention of diseases, disorders and conditions in the area of oncology; Pharmaceutical and veterinary products and preparations for the treatment and prevention of diseases, disorders and conditions in the area of gastroenterology; Pharmaceutical and veterinary products and preparations for the treatment and prevention of diseases, disorders and conditions in the area of neurology; Pharmaceutical and veterinary products and preparations for the treatment and prevention of diseases, disorders and conditions in the area of gynecology; Pharmaceutical and veterinary products and preparations for the treatment and prevention of diseases, disorders and conditions in the area of urology; Pharmaceutical and veterinary products and preparations for the treatment and prevention of diseases, disorders and conditions in the area of cardiology; Pharmaceutical and veterinary products and preparations for the treatment and prevention of diseases, disorders and conditions in the area of endocrinology; Pharmaceutical and veterinary products and preparations for the treatment and prevention of diseases, disorders and conditions in the area of nephrology; Pharmaceutical and veterinary products and preparations for the treatment and prevention of diseases, disorders and conditions in the area of hematology; Pharmaceutical and veterinary products and preparations for the treatment and prevention of diseases, disorders and conditions in the area of allergy; Pharmaceutical and veterinary products and preparations for the treatment and prevention of diseases, disorders and conditions in the area of immunology; Pharmaceutical and veterinary products and preparations for the treatment and prevention of diseases, disorders and conditions in the area of psychiatry; Pharmaceutical and veterinary products and preparations for the treatment and prevention of diseases, disorders and conditions in the area of anesthesiology; Pharmaceutical and veterinary products and preparations for the treatment and prevention of diseases, disorders and conditions in the area of rheumatology; all of the aforesaid for prescription only
  • GS0011: Chemical substances for use in the manufacture of pharmaceutical preparations for the treatment of dermatological conditions and for the treatment of infections and diseases; chemical substances for use in research and development of pharmaceuticals for the treatment of dermatological conditions and for the treatment of infections and diseases; diagnostic preparations for scientific clinical use; diagnostic reagents for clinical or medical laboratory use
  • DS0000: "PHARMACEUTICALS"
  • GS0421: Research and development services for third parties in the field of chemical substances, pharmaceutical and veterinary products and preparations
Case File Event Statements
  • 8/11/2022 - 2 years ago
    1 - NEW APPLICATION ENTERED Type: NWAP
  • 8/29/2022 - 2 years ago
    2 - NEW APPLICATION OFFICE SUPPLIED DATA ENTERED Type: NWOS
  • 5/24/2023 - a year ago
    3 - ASSIGNED TO EXAMINER Type: DOCK
  • 5/24/2023 - a year ago
    4 - EXAMINERS AMENDMENT -WRITTEN Type: CNEA
  • 5/24/2023 - a year ago
    5 - EXAMINERS AMENDMENT E-MAILED Type: GNEA
  • 5/24/2023 - a year ago
    6 - NOTIFICATION OF EXAMINERS AMENDMENT E-MAILED Type: GNEN
  • 5/24/2023 - a year ago
    7 - EXAMINER'S AMENDMENT ENTERED Type: XAEC
  • 5/24/2023 - a year ago
    8 - APPROVED FOR PUB - PRINCIPAL REGISTER Type: CNSA
  • 6/27/2023 - a year ago
    10 - PUBLISHED FOR OPPOSITION Type: PUBO
  • 6/7/2023 - a year ago
    9 - NOTIFICATION OF NOTICE OF PUBLICATION E-MAILED Type: NONP
  • 6/27/2023 - a year ago
    11 - OFFICIAL GAZETTE PUBLICATION CONFIRMATION E-MAILED Type: NPUB
  • 8/22/2023 - a year ago
    12 - NOA E-MAILED - SOU REQUIRED FROM APPLICANT Type: NOAM
  • 2/16/2024 - 11 months ago
    14 - SOU EXTENSION 1 FILED Type: EXT1
  • 2/16/2024 - 11 months ago
    13 - SOU TEAS EXTENSION RECEIVED Type: EEXT
  • 8/13/2024 - 5 months ago
    17 - SOU TEAS EXTENSION RECEIVED Type: EEXT
  • 8/14/2024 - 5 months ago
    20 - NOTICE OF APPROVAL OF EXTENSION REQUEST E-MAILED Type: EXRA
  • 8/14/2024 - 5 months ago
    19 - SOU EXTENSION 2 GRANTED Type: EX2G
  • 8/14/2024 - 5 months ago
    18 - SOU EXTENSION 2 FILED Type: EXT2
  • 2/17/2024 - 10 months ago
    16 - NOTICE OF APPROVAL OF EXTENSION REQUEST E-MAILED Type: EXRA
  • 2/16/2024 - 11 months ago
    15 - SOU EXTENSION 1 GRANTED Type: EX1G